This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of various biologically active molecules, particularly those targeting neurological and psychiatric disorders. Its unique spirocyclic structure and trifluoromethyl group enhance its potential in drug discovery, as it can improve the metabolic stability and bioavailability of therapeutic agents. Researchers often employ it in the development of novel compounds for treating conditions such as depression, anxiety, and neurodegenerative diseases. Additionally, its incorporation into small molecules can aid in the exploration of new chemical spaces, enabling the identification of innovative drug candidates.